Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
PaperCitations, authors & open-access status
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 458 citations, 2019 year and hybrid oa status.
458
Citations
2019
Year
hybrid
OA Status